Search - tctmd.com

Displaying 341 - 350 of 350

Sort: Relevancy | Date

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Industry News

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

June 25, 2015

Presentation TCT 2014

Innovative Technologies to Reduce and Monitor Contrast Dosage During Angiography

Presenter: Chaim S. Lotan, Julio C. Palmaz, Mark A. Turco, Roxana Mehran

September 15, 2014

Presentation TCT 2013

Case Review: A Patient With Several Recent Complex PCIs Referred for Repeat Intervention: Managing Heavy Contrast and Radiation Exposure

Presenter: Stephen Balter

October 31, 2013

Presentation TCT 2013

The Effect of Automated Contrast Injection Systems on Contrast Volume Use During Diagnostic Coronary Angiography And Percutaneous Coronary Interventions

Presenter: Joshua Hwang, Shahar Lavi

January 31, 2013

Presentation TCT 2013

Contrast Agent and Radiation Exposure in Revascularisation of Chronic Coronary Total Occlusions: Magnetic Navigation versus Conventional Percutaneous Coronary Intervention

Presenter: Sabine Scherzer, Berger Rudolf, Lisa Krenn, Clemens Gangl, Christian Roth, Natalija Lajic, Georg Delle Karth, Thomas Neunteufl

January 31, 2013

News Daily News

Late-Night Calls Do Not Adversely Affect Operators’ Next-Day PCI

Leah Lawrence

April 10, 2012

News Daily News

Las Llamadas a Altas Horas de la Noche No Afectan las PCI que realizan los Operadores al Día Siguiente

Leah Lawrence

April 10, 2012

News Conference News

SCAI Launches Nationwide Cath Lab Quality Improvement Effort

Jason Kahn

May 09, 2011

Advertisement

Meta-analysis Confirms Safety of PCI without Surgical Backup

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

Innovative Technologies to Reduce and Monitor Contrast Dosage During Angiography

Case Review: A Patient With Several Recent Complex PCIs Referred for Repeat Intervention: Managing Heavy Contrast and Radiation Exposure

The Effect of Automated Contrast Injection Systems on Contrast Volume Use During Diagnostic Coronary Angiography And Percutaneous Coronary Interventions

Contrast Agent and Radiation Exposure in Revascularisation of Chronic Coronary Total Occlusions: Magnetic Navigation versus Conventional Percutaneous Coronary Intervention

Late-Night Calls Do Not Adversely Affect Operators’ Next-Day PCI

Las Llamadas a Altas Horas de la Noche No Afectan las PCI que realizan los Operadores al Día Siguiente

SCAI Launches Nationwide Cath Lab Quality Improvement Effort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content